/
An overview of the EC’s research initiatives for healthcare An overview of the EC’s research initiatives for healthcare

An overview of the EC’s research initiatives for healthcare - PowerPoint Presentation

tatyana-admore
tatyana-admore . @tatyana-admore
Follow
346 views
Uploaded On 2018-12-04

An overview of the EC’s research initiatives for healthcare - PPT Presentation

Dr Karim Berkouk Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission Ageing population Increased disease burden chronic diseases Health amp care sector unsustainable ID: 734609

research health amp disease health research disease amp respiratory european diseases care ageing copd technologies www lung patients innovative

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "An overview of the EC’s research initi..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

An overview of the EC’s research initiatives for healthcare

Dr Karim Berkouk,Deputy Head of UnitDG for Research and InnovationHealth DirectorateEuropean Commission Slide2

Ageing population

Increased disease burden: chronic diseasesHealth & care sector unsustainable: under pressure to reformHealth industry under pressure for innovative solution

Health main challengesSlide3

Early

origins of lung diseases: prenatal nutritional deficiencies or maternal smoking; severe early infections; genetic and epigenetic factors related to the natural and anthropogenic environmentLifestyle and lung health: nutrition, active and passive smoking, physical inactivity, social inequitiesEnvironment: ozone and particulate matters , occupational exposure, indoor air quality and nanomaterials Early diagnosis, vaccines and treatments (especially for resistant pathogens) lung infectionsAgeing population: comorbidities, increased disease and economic burden

Respiratory Diseases (RD) main

challenges

From the European

Respiratory

roadmap

. Recommendations for the future of respiratory medicine. European Respiratory Society. 2011. Slide4

The EU meansSlide5

FP 7 - State of Play

Health researchKey figures5,5 b€ invested to date1053 projects12 520 participations3 615 organisations 123 countries

First outcomes

(on

363

closed projects)

12 269

publications

3,1

average

SJR* publication

228 patent applications 31 spin-offs created

* SCImago Journal RankingSlide6

basic research

translational research COPD Pneumonia Asthma TuberculosisCollaborative research: 236

Frontier Research: 32

SME: 9

Training & Mobility: 14

290

Million on

Respiratory Diseases

(in million Euro)Slide7

Large

cohort studies in asthma and COPD by studying specific genetic markers and related phenotypes e.g.:longitudinal, population based studies: MeDALL, COPACETIC, EVA, ESCAPE birth cohort studies: CHICOS Drug development, personalised medicine & TechnologyPrognostic & PM: AirPROM, U-BIOPREDTechnology for home care (HOMECARE) and bio-artificial lung (Ambulung )

Respiratory infections

(e.g

.

TB ;

antimicrobial

resistance)Coordinating research in RD in Europe (EARIP)

FP7 Overview 2007-2013 Slide8

€ 16.8 million

http://www.proactivecopd.com

Aim: to

develop new tools that will enable patients, their doctors and clinical researchers

to accurately assess the improvement or deterioration

of

COPD.

Tools tested on more

than 600 COPD

patients:

A

user friendly electronic tool will help patients to assess on a day-to-day basis the activities in which they engage and the symptoms associated to these activities.

Another

tool

will be used during hospital visits to assess the patients' physical activity and experience of the disease.

Physical

Activity as a Crucial Patient Reported Outcome in

COPD (

PROactive

)Slide9

Horizon 2020

PerspectivesSlide10

Three

prioritiesExcellent scienceIndustrial leadershipSocietal challenges

European Research Council

Future and Emerging Technologies

Marie

Skłodowska

-Curie actions

Research infrastructures

Leadership in enabling and industrial technologies

Access to risk finance

Innovation in SMEs

Health, demographic change and wellbeing

Food security, sustainable agriculture and forestry, marine and maritime and inland water research and the

Bioeconomy

Secure, clean and efficient energy

Smart, green and integrated transport

Climate action, environment, resource efficiency and raw materials

Inclusive, innovative and reflective societies

Secure societies

Science with and for society

Spreading excellence and widening participation

Budget:

about €79 BillionSlide11

Advancing active and healthy ageing

Integrated, sustainable, citizen-centred care

Improving health information, data exploitation and providing an evidence base for health policies and regulation

Innovative treatments and technologies

Improving diagnosis

Effective health promotion, disease prevention,

preparedness and screening

Understanding health, ageing & disease

WP 2014/2015: €

1,2

billion

Funding: € 7.5 Billion

Health, Demographic change and

wellbeingSlide12

Understanding health, ageing and disease: determinants, risk factors and pathways

Comparing the effectiveness of existing healthcare interventions in the elderlyNew therapies for chronic non-communicable diseases Health promotion and disease prevention: translating ‘omics’ into stratified approaches Evaluating existing screening and prevention programmesAdvancing bioinformatics to meet biomedical and clinical needs Topics 2014 relevant for RDSlide13

Understanding common mechanisms of diseases and their relevance in

co-morbiditiesHealth promotion and disease prevention (environment and health based interventions)Development of new diagnostic tools and technologies: in vivo medical imaging technologiesTools and technologies for advanced therapies Establishing effectiveness of health care interventions in the paediatric populationPiloting personalised medicine in health and care systemsTopics 2015 relevant for RDSlide14

Strategic Initiatives

Innovative Medicines Initiative 2 www.imi.europa.eu

European & Developing Countries Clinical Trials Partnership (EDCTP2)

www.edctp.org

Active and Assisted Living 2

www.aal-europe.eu

European Innovation Partnership on Active and Healthy Ageing

https://webgate.ec.europa.eu/eipahaSlide15

International

cooperation: how?Identify and define sharedstrategic goalsAgree to approach jointly andshare tasks (and costs)Let each agency use its own funding mechanisms/timingAgree to share data / standards

Alignment – Flexibility

– Commitment

Example: Global Alliance for Chronic Diseases (GACD)